Home

Urma Produs secundar camuflaj ac anti epstein barr vca igg Categorie Generaliza autoritate

Frontiers | Serological Evidence for the Association Between Epstein-Barr  Virus Infection and Sjögren's Syndrome
Frontiers | Serological Evidence for the Association Between Epstein-Barr Virus Infection and Sjögren's Syndrome

Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers  detected by xMAP technology | Journal of Translational Medicine | Full Text
Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology | Journal of Translational Medicine | Full Text

Epstein-Barr Virus, EBV virus infection
Epstein-Barr Virus, EBV virus infection

Epstein Barr Virus Antigen - an overview | ScienceDirect Topics
Epstein Barr Virus Antigen - an overview | ScienceDirect Topics

Test
Test

Complete Epstein-Barr virus seropositivity in a large cohort of patients  with early multiple sclerosis | Journal of Neurology, Neurosurgery &  Psychiatry
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis | Journal of Neurology, Neurosurgery & Psychiatry

T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic  Epstein–Barr Virus Infections | NEJM
T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus Infections | NEJM

Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear  Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic  Simulations | ACS Chemical Neuroscience
Identification of Potential Inhibitors against Epstein–Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations | ACS Chemical Neuroscience

A potent and protective human neutralizing antibody targeting a novel  vulnerable site of Epstein-Barr virus | Nature Communications
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications

Progress and Problems in Understanding and Managing Primary Epstein-Barr  Virus Infections | Clinical Microbiology Reviews
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews

The role of Epstein-Barr virus in multiple sclerosis: from molecular  pathophysiology to in vivo imaging. - Abstract - Europe PMC
The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging. - Abstract - Europe PMC

VIDAS EBV panel, diagnosis of Mononucleosis | bioMérieux Clinical  Diagnostics
VIDAS EBV panel, diagnosis of Mononucleosis | bioMérieux Clinical Diagnostics

Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case  Control Study | Journal of Kermanshah University of Medical Sciences | Full  Text
Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case Control Study | Journal of Kermanshah University of Medical Sciences | Full Text

Plasma anti-EBV antibodies in pSS patients from ASSESS cohort. The... |  Download Scientific Diagram
Plasma anti-EBV antibodies in pSS patients from ASSESS cohort. The... | Download Scientific Diagram

Anti-Epstein–Barr virus antibodies as serological markers of multiple  sclerosis: a prospective study among United States military personnel - KL  Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011
Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011

VIRUS EPSTEIN-BARR (VCA IgG) - Analisi Papagni
VIRUS EPSTEIN-BARR (VCA IgG) - Analisi Papagni

Antibodies | Free Full-Text | EBNA1 IgM-Based Discrimination Between  Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and  Healthy Controls | HTML
Antibodies | Free Full-Text | EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls | HTML

Epstein-Barr Virus (VCA) IgG and IgG Avidity ELISA - VIDIA | MoBiTec  Molecular Biotechnology
Epstein-Barr Virus (VCA) IgG and IgG Avidity ELISA - VIDIA | MoBiTec Molecular Biotechnology

Ac Anti-Epstein Barr EBNA IgG, VCA IgG, VCA IgM | MedLife
Ac Anti-Epstein Barr EBNA IgG, VCA IgG, VCA IgM | MedLife

Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort:  A two-years longitudinal study
Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging  Immunotherapies: Trends in Molecular Medicine
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: Trends in Molecular Medicine

Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus  Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands |  SpringerLink
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands | SpringerLink

Epstein-Barr Virus | Bio-Rad
Epstein-Barr Virus | Bio-Rad

Anti-Epstein–Barr virus antibodies as serological markers of multiple  sclerosis: a prospective study among United States military personnel - KL  Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011
Anti-Epstein–Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel - KL Munger, LI Levin, EJ O'Reilly, KI Falk, A Ascherio, 2011

Vaccines | Free Full-Text | An Absence of Epstein–Barr Virus Reactivation  and Associations with Disease Activity in People with Multiple Sclerosis  Undergoing Therapeutic Hookworm Vaccination | HTML
Vaccines | Free Full-Text | An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination | HTML